Receptor heterogeneity of human breast cancer as measured by multiple intratumoral assays of estrogen and progesterone receptor

Eur J Cancer Clin Oncol. 1984 Mar;20(3):375-82. doi: 10.1016/0277-5379(84)90084-1.

Abstract

Multiple intratumoral tissue samples from the primary mass of 30 consecutive invasive breast cancer patients were assayed for estrogen receptor (ER) and progesterone receptor (PR) by the dextran-coated charcoal method following frozen section histopathological examination. Steroid receptor status of each sample was classified as positive (R+) or negative (R-), based only upon quantitative guide lines from the ER/PR results. Four out of 32 (12.5%) of the invasive cancers had an intratumoral sample classified as R+ and one sample as R-. R+ invasive ductal carcinomas has a highly significant degree of tubule formation (P = 0.005) when compared with R- invasive ductal cancers. While the quantitative ER content (r = 0.18) and the degree of quantitative variation in ER content (P = 0.04) did not correlate with the tumor cellularity of the individual samples, tumor cellularity (P = 0.005) and ER content (P = 0.005) were lower in the samples from the tumor border than from the central tumor samples. Variations in ER and PR content may be found on a regional basis within a breast tumor mass resulting from heterogeneity of tumor subpopulations and/or differences in tumor cellularity.

MeSH terms

  • Adult
  • Aged
  • Breast Neoplasms / analysis*
  • Breast Neoplasms / pathology
  • Carcinoma in Situ / analysis
  • Carcinoma, Intraductal, Noninfiltrating / analysis
  • Female
  • Humans
  • Middle Aged
  • Receptors, Estrogen / analysis*
  • Receptors, Progesterone / analysis*

Substances

  • Receptors, Estrogen
  • Receptors, Progesterone